Ergebnis der Suchanfrage nach celle

Acousia Therapeutics GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small ...

nova-Institut GmbH

3

CO₂-based Fuels and Chemicals Conference 2026: Preliminary Program Now Available

STADA Arzneimittel AG

Press Release: STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe

STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe - European Commission approves STADA’s Kefdensis® and Zvogra® denosumab biosimilars for all indications of reference medicines Prolia® and ...

Asklepios Kliniken GmbH & Co. KGaA

Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award

Wiesbaden, Germany (ots) - - Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy - One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time - Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical ...

GEA Group Aktiengesellschaft

2

GEA kytero® 2000 : co-operation GEA and Rockwell Automation

FMC

Semiconductor pioneer FMC raises €100 million to set new standards for memory chips

Dresden (ots) - - Oversubscribed financing round consisting of €77 million in Series C equity capital, led by HV Capital and DTCF, and €23 million in public funding, marking one of the largest capital rounds in the European semiconductor sector - Fresh capital accelerates the commercialization of FMC DRAM+ and 3D CACHE+ memory chips to enable the global ramp-up of ...

GEA Group Aktiengesellschaft

2

Partnership agreement between GEA and I&L Biosystems

Technische Universität München

Nanorobots transform stem cells into bone cells

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE New method for the targeted production of specific cells Nanorobots transform stem cells into bone cells - Mechanical stimulation can transform stem cells into bone cells. - Researchers have demonstrated that cells can be reliably transformed in a system using nanorobots and laser light. - In principle this method can also be used to produce heart and cartilage cells. For the ...

Sentorise

Sentorise Launches the 12.8V 100AH Group31: Reliable, Sustainable Power for Europe

Berlin, Germany (ots) - Sentorise has launched its 12.8V 100Ah Group 31 LiFePO₄ battery in Europe, providing a reliable power solution for RV travelers, off-grid homes, and marine users. With long life, built-in safety, and smart monitoring, it’s designed for dependable off-grid and backup energy. It’s the first in Europe to offer full-series low-temperature ...

Vaccentis AG

Letter of Intent for strategic partnership / Vaccentis and TrueMed join forces to advance cancer vaccine

Zurich (ots) - Vaccentis, a Zurich based biotech company specializing in the development of therapeutic protein-based tumor vaccines, has signed a letter of intent with TrueMed, a leading commercialization partner. Accelerating cancer vaccine against renal cell carcinoma The aim of this letter of intent is to ...

PLAN-B NET ZERO

PLAN-B NET ZERO presents resilience concept combining Battery Energy Storage Systems (BESS), Hydrogen and AI at the D-A-CH Hydrogen Symposium

Fraunhofer-Institut für Produktionstechnologie IPT

More power in a smaller space: Compact press system for manufacturing hydrogen components

Kerry Group

Kerry Establishes New Biotechnology Centre in Leipzig / Centre to facilitate cutting-edge innovations with wide range of applications across food, beverage and pharma

Leipzig (ots) - Kerry, a global leader in taste and nutrition, has today inaugurated the Kerry Biotechnology Centre in Leipzig, Germany, which will focus on the development of innovative biotech solutions across food, beverage, and pharma applications. New capabilities in biotechnology are opening the field to ...

Asklepios Kliniken GmbH & Co. KGaA

2

Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025

DHL Group

PM: DHL übernimmt SDS Rx und stärkt damit seine Kompetenzen im Bereich Life Sciences und Healthcare / PR: DHL Agrees to Acquire SDS Rx Expanding Its Life Sciences and Healthcare Capabilities

Technische Universität München

Slime as a material for multifunctional spheres

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Hollow microparticles for cargo molecules Slime as a material for multifunctional spheres - Hollow microspheres for molecular cargoes combine multiple functions - They adhere effectively to soft tissue and cartilage - Potential future applications in osteoarthritis or for oral ulcers Researchers at the Technical University of Munich (TUM) have developed hollow microspheres made ...

UCB

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...

Infineon Technologies AG

Infineon strengthens startup ecosystem in India

DHL Group

PM: DHL Group erzielt Ergebniswachstum im zweiten Quartal 2025 / PR: DHL Group: earnings growth in the second quarter of 2025

DHL Group erzielt Ergebniswachstum im zweiten Quartal 2025 - Konzernumsatz sinkt durch Wechselkurseffekte und ein geringeres Momentum der Handelsvolumen im zweiten Quartal um 3,9 Prozent auf 19,8 Milliarden Euro (Q2 2024: 20,6 Milliarden Euro) - EBIT ...

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

PNO Innovation GmbH

TherVacB: Advance Curative Strategy for Chronic Hepatitis B

Helmholtz Munich

Cancer Cachexia: Liver Identified as Driver of Body Wasting

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...

GEA Group Aktiengesellschaft

5

GEA opens New Food technology center in the U.S. to boost alternative proteins’ scale-up

Helmholtz Munich

2

New Label-Free Imaging Tracks Cancer Treatment in Single Cells